Surveillance of congenital cytomegalovirus in the UK and Ireland

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 96, Issue 6, 2011, Pages

  Townsend, Claire L ^a   Peckham, Catherine S ^a   Tookey, Pat A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

ARTICLE; CLINICAL ASSESSMENT; CONGENITAL INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FOLLOW UP; GESTATIONAL AGE; HEARING LOSS; HUMAN; IRELAND; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NEWBORN; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREMATURITY; PRIORITY JOURNAL; QUESTIONNAIRE; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT DURATION; UNITED KINGDOM; VIRUS ISOLATION;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; DEVELOPMENTAL DISABILITIES; FEMALE; GANCICLOVIR; GESTATIONAL AGE; GREAT BRITAIN; HEARING LOSS, BILATERAL; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; IRELAND; MALE; POPULATION SURVEILLANCE; PROGNOSIS; TREATMENT OUTCOME;

EID: 80054733884     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2010.199901     Document Type: Article

References (35)

1. Tookey PA, Ades AE, Peckham CS. Cytomegalovirus prevalence in pregnant women: the influence of parity. Arch Dis Child 1992;67:779-83.
2. Gaytant MA, Steegers EA, Semmekrot BA, et al. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 2002;57:245-56. (Pubitemid 34407101)
3. Ahlfors K, Ivarsson SA, Harris S, et al. Congenital cytomegalovirus infection and disease in Sweden and the relative importance of primary and secondary maternal infections. Preliminary findings from a prospective study. Scand J Infect Dis 1984;16:129-37. (Pubitemid 14104146)
4. Peckham CS, Chin KS, Coleman JC, et al. Cytomegalovirus infection in pregnancy: preliminary findings from a prospective study. Lancet 1983;1:1352-5. (Pubitemid 13100197)
5. Griffiths PD, Baboonian C, Rutter D, et al. Congenital and maternal cytomegalovirus infections in a London population. Br J Obstet Gynaecol 1991;98:135-40.
6. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007;17:355-63. (Pubitemid 47425872)
7. Ahlfors K, Ivarsson SA, Harris S. Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature. Scand J Infect Dis 1999;31:443-57. (Pubitemid 29516202)
8. Ramsay ME, Miller E, Peckham CS. Outcome of confirmed symptomatic congenital cytomegalovirus infection. Arch Dis Child 1991;66:1068-9.
9. Kumar ML, Nankervis GA, Jacobs IB, et al. Congenital and postnatally acquired cytomegalovirus infections: long-term follow-up. J Pediatr 1984;104:674-9. (Pubitemid 14111027)
10. Kimberlin DW, Lin CY, Sánchez PJ, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003;143:16-25. (Pubitemid 36928564)
11. Whitley RJ, Cloud G, Gruber W, et al. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1997;175:1080-6. (Pubitemid 27176494)
12. Ludwig A, Hengel H. Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. Euro Surveill 2009;14:26-32.
13. Peckham CS, Johnson C, Ades A, et al. Early acquisition of cytomegalovirus infection. Arch Dis Child 1987;62:780-5. (Pubitemid 17128824)
14. Maschmann J, Hamprecht K, Dietz K, et al. Cytomegalovirus infection of extremely low-birth weight infants via breast milk. Clin Infect Dis 2001;33:1998-2003. (Pubitemid 33152393)
15. Grosse SD, Dollard S, Ross DS, et al. Newborn screening for congenital cytomegalovirus: options for hospital-based and public health programs. J Clin Virol 2009;46(Suppl 4):S32-6.
16. Barbi M, Binda S, Caroppo S. Diagnosis of congenital CMV infection via dried blood spots. Rev Med Virol 2006;16:385-92. (Pubitemid 44763839)
17. British Paediatric Surveillance Unit. 18th Annual Report, 2003-2004. London: Royal College of Paediatrics and Child Health, 2004. http://www.bpsu.inopsu.com (accessed 10 October 2010).
18. Lynn R, Ross E. The British Paediatric Surveillance Unit: the first 20 years. Arch Dis Child 2007;92:744-5. (Pubitemid 47372521)
19. Lynn RM, Pebody R, Knowles R. Twenty years of active paediatric surveillance in the the UK and Republic of Ireland. Euro Surveill 2006;11:E060720.4.
20. Cole TJ, Freeman JV, Preece MA. British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Stat Med 1998;17:407-29. (Pubitemid 28057006)
21. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 1992;11:1305-19.
22. Office for National Statistics. Birth Statistics: Review of the Registrar General on Births and Patterns of Family Building in England and Wales, 2005. London: HMSO, 2006. http://www.statistics.gov.uk/downloads/theme-population/ FM1-34/FM1-no34-2005.pdf (accessed 10 October 2010).
23. Munro SC, Trincado D, Hall B, et al. Symptomatic infant characteristics of congenital cytomegalovirus disease in Australia. J Paediatr Child Health 2005;41:449-52. (Pubitemid 41633108)
24. Yamamoto AY, Mussi-Pinhata MM, Cristina P, et al. Congenital cytomegalovirus infection in preterm and full-term newborn infants from a population with a high seroprevalence rate. Pediatr Infect Dis J 2001;20:188-92. (Pubitemid 32151943)
25. Luck S, Sharland M. Postnatal cytomegalovirus: innocent bystander or hidden problem? Arch Dis Child Fetal Neonatal Ed 2009;94:F58-64.
26. Greenough A. The TORCH screen and intrauterine infections. Arch Dis Child Fetal Neonatal Ed 1994;70:F163-5. (Pubitemid 24183498)
27. TORCH syndrome and TORCH screening. Lancet 1990;335:1559-61.
28. Atkinson C, Walter S, Sharland M, et al. Use of stored dried blood spots for retrospective diagnosis of congenital CMV. J Med Virol 2009;81:1394-8.
29. Soetens O, Vauloup-Fellous C, Foulon I, et al. Evaluation of different cytomegalovirus (CMV) DNA PCR protocols for analysis of dried blood spots from consecutive cases of neonates with congenital CMV infections. J Clin Microbiol 2008;46:943-6. (Pubitemid 351379984)
30. Barbi M, Binda S, Primache V, et al. Cytomegalovirus DNA detection in Guthrie cards: a powerful tool for diagnosing congenital infection. J Clin Virol 2000;17:159-65.
31. Grosse SD, Ross DS, Dollard SC. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol 2008;41:57-62. (Pubitemid 351179445)
32. Foulon I, Naessens A, Foulon W, et al. A 10-year prospective study of sensorineural hearing loss in children with congenital cytomegalovirus infection. J Pediatr 2008;153:84-8.
33. Fowler KB, Boppana SB. Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol 2006;35:226-31. (Pubitemid 43053405)
34. Williamson WD, Demmler GJ, Percy AK, et al. Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics 1992;90:862-6.
35. Adler SP, Nigro G, Pereira L. Recent advances in the prevention and treatment of congenital cytomegalovirus infections. Semin Perinatol 2007;31:10-18. (Pubitemid 46273658)